Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-associated Circulatory Overload (2026 Edition)

doi:10.3969/j.issn.1671-2587.2026.01.001

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (1): 1-8.DOI: 10.3969/j.issn.1671-2587.2026.01.001

Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-associated Circulatory Overload (2026 Edition)

Writing Group of Expert Consensus on the Clinical Diagnosis, Treatment of Transfusion-associated Circulatory Overload, Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion

Received:2026-01-01 Published:2026-02-13

Abstract

Abstract: Transfusion-associated circulatory overload (TACO) is a severe transfusion complication. The Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion (CSBT) organized domestic experts and scholars from disciplines including transfusion medicine, hematology, cardiology, pulmonology, and critical care medicine to formulate the Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-Associated Circulatory Overload (2026 Edition). This consensus puts forward expert recommendations on TACO-related auxiliary examinations, diagnosis and differential diagnosis, prevention, and treatment strategies, aiming to further improve the standard of TACO diagnosis and treatment in China.

Key words: Transfusion-associated circulatory overload, Blood components, Pulmonary edema, Dyspnea

CLC Number:

R457

Writing Group of Expert Consensus on the Clinical Diagnosis, Treatment of Transfusion-associated Circulatory Overload, Working Party on Clinical Transfusion, Chinese Society of Blood Transfusion. Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-associated Circulatory Overload (2026 Edition)[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2026, 28(1): 1-8.

References

[1] BULLE E B,KLANDERMAN R B,DE WISSEL M B, et al. The effect of plasma transfusion in an experimental two-hit animal model of transfusion-associated circulatory overload with heart failure[J]. Blood Transfus, 2023,21(3):218-226.
[2] SCHIPPERUS M R,WIERSUM-OSSELTON J C. Updated definitions for respiratory complications of blood transfusion[J]. Transfusion,2019,59(7):2482-2483.
[3] Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol[EB/OL]. (2022-02-11). https://www.cdc.gov/nhsn/pdfs/biovigilance/bv-hv-protocol-current.pdf.
[4] International Society of Blood Transfusion Working Party on Haemovigilance. Transfusion-associated circulatory overload (TACO) definition.2018 [cited 2021 Jul 24]. Available from: https://www.isbtweb.org/resource/tacodefinition.html.
[5] JHA S,PATEL K V,BUKHARI A.Chronicle of hypoxemia: transfusion-associated circulatory overload versus transfusion-related acute lung injury[J]. Cureus, 2022,14(9):e28712.
[6] Narayan S, editor, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The2019 Annual SHOT Report[EB/OL].[2025-12-13]. https://www.shotuk.org/wp-content/uploads/myimages/SHOT-REPORT-2019-Final-Bookmarked-v2.pdf.
[7] US Food and Drug Administration. Fatalities Reported to FDA Following Blood Collection and Transfusion Annual Summary for FY2019[EB/OL].[2025-12-13]. https://www.fda.gov/media/147628/download.
[8] BOSBOOM J J,KLANDERMAN R B,MIGDADY Y,et al.Transfusion-associated circulatory overload: a clinical perspective[J]. Transfus Med Rev,2019,33(2):69-77.
[9] BOSBOOM J J,KLANDERMAN R B,ZIJP M,et al.Incidence,risk factors,and outcome of transfusion-associated circulatory overload in a mixed intensive care unit population: a nested case-control study[J]. Transfusion,2018,58(2):498-506.
[10] GOEL R,TOBIAN A A R,SHAZ B H. Noninfectious transfusion-associated adverse events and their mitigation strategies[J]. Blood,2019,133(17):1831-1839.
[11] ROUBINIAN N H,HENDRICKSON J E,TRIULZI D J, et al.Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm[J]. Vox Sang,2017,112(1):56-63.
[12] United States Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year2017[EB/OL].(2022-01-06). https://www.fda.gov/media/124796/download.
[13] 梁春艳,段莉,刘友迎,等. 住院患者输血相关循环超负荷的危险因素及预测模型的构建与验证[J]. 临床输血与检验,2024,26(6):771-776.
[14] 唐聪海,黄燕雪,林艺璇,等. 输血不良反应相关因素分析[J]. 中国实验血液学杂志,2020,28(3):972-976.
[15] YUAN Y,DENNINGTON P M,DALY J,et al.The impact of revised definitions for transfusion-associated circulatory overload and transfusion-related acute lung injury on haemovigilance reporting[J]. Vox Sang, 2023,118(3):199-206.
[16] VAN DEN AKKER T A,GRIMES Z M,FRIEDMAN M T. Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Am J Clin Pathol,2021,156(4):529-539.
[17] ROUBINIAN N.TACO and TRALI: biology,risk factors,and prevention strategies[J]. Hematology Am Soc Hematol Educ Program,2018,2018(1):585-594.
[18] 《输血相关急性肺损伤诊治中国专家共识》编写组,周吉成,于洋,等. 输血相关急性肺损伤诊治中国专家共识(2023版)[J]. 临床输血与检验,2023,25(5):577-585.
[19] SEMPLE J W,REBETZ J,KAPUR R.Transfusion-associated circulatory overload and transfusion-related acute lung injury[J]. Blood,2019,133(17):1840-1853.
[20] ROUBINIAN N H,TRIULZI D J.Transfusion-associated circulatory overload and transfusion-related acute lung injury: etiology and prevention[J]. Hematol Oncol Clin North Am,2019,33(5):767-779.
[21] 葛均波,王辰,王建安主编. 内科学[M].10版.北京:人民卫生出版社,2024.
[22] 中国医疗保健国际交流促进会急诊医学分会,中华医学会急诊医学分会,中国医师协会急诊医师分会,等. 急性心力衰竭中国急诊管理指南(2022)[J]. 临床急诊杂志, 2022,23(08):519-547.
[23] ESPINOSA A,GARVIK L J,TRUNG NGUYEN N,et al.A fatal case of acute hemolytic transfusion reaction caused by anti-Wr(a): case report and review of the literature[J]. Immunohematology,2021,37(1):20-24.
[24] JOHNSON-ARBOR K,GILSTAD C,VERSTRAETE R.A potential food-related acute allergic transfusion reaction[J]. Blood Transfus,2024,22(4):367-368.
[25] WEBB C,NORRIS A,HANDS K.An acute transfusion reaction[J]. Clin Med,2018,18(1):95-97.
[26] TACQUARD C,BOUDJEDIR K,CARLIER M,et al.Hypersensitivity transfusion reactions due to IgA deficiency are rare according to French hemovigilance data[J]. J Allergy Clin Immunol,2017,140(3):884-885.
[27] WIERSUM-OSSELTON J C,WHITAKER B,GREY S, et al. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study[J]. Lancet Haematol,2019,6(7): e350-e358.
[28] NISHIKIMI T,NAKAGAWA Y.Potential pitfalls when interpreting plasma BNP levels in heart failure practice[J]. J Cardiol,2021,78(4):269-274.
[29] RICHARDS A M.BNP as a biomarker in adult congenital heart disease: help or hype?[J]. Eur Heart J, 2024,45(23):2076-2078.
[30] AMMAR L A,MASSOUD G P,CHIDIAC C,et al.BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis[J]. Heart Fail Rev, 2025,30(1):45-54.
[31] KLANDERMAN R B,BOSBOOM J J,MIGDADY Y,et al.Transfusion-associated circulatory overload-a systematic review of diagnostic biomarkers[J]. Transfusion,2019, 59(2):795-805.
[32] MCDONAGH TA,METRA M,ADAMO M,et al.2021 ESC Guidelines for thediagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2021,42(36): 3599-3726.
[33] SMITH C M.CE: recognizing transfusion-associated circulatory overload[J]. Am J Nurs,2023,123(11):34-41.
[34] SONI L,SAEED S,CSERTI-GAZDEWICH C,et al.Mortality-associated risk factors for transfusion-associated circulatory overload[J]. Vox Sang,2024,119(9):996-1000.
[35] VAN WONDEREN S F,KLANDERMAN R B,VLAAR A P J. Understanding transfusion-related acute lung injury (TRALI) and its complex pathophysiology[J]. Blood Transfus,2022,20(6):443-445.
[36] GOGOS C,STAMOS K,TSANAXIDIS N,et al.Blood transfusion components inducing severe allergic reactions: the first case of kounis syndrome induced by platelet transfusion[J]. Vaccines,2023,11(2):220.
[37] BADAMI K G,JOLIFFE E,STEPHENS M.Transfusion-associated dyspnea—shadow or substance?[J]. Vox Sang,2015,109(2):197-200.
[38] HIRAYAMA F.Current understanding of allergic transfusion reactions: incidence,pathogenesis,laboratory tests,prevention and treatment[J]. Br J Haematol,2013, 160(4):434-444.
[39] AUBRON C,HOURMANT B,MENGUY J,et al.Transfusion-related respiratory complications in intensive care: A diagnosis challenge[J]. Transfus Clin Biol,2021,28(4):344-348.
[40] KLANDERMAN R B,WIJNBERGE M,BOSBOOM J J,et al.Differential effects of speed and volume on transfusion-associated circulatory overload: A randomized study in rats[J]. Vox Sang,2022,117(3):371-378.
[41] FADEYI O A,KERESZTES P,SAHA A K,et al.Preventing transfusion-associated circulatory overload in acute care settings[J]. Nursing,2023,53(6):37-41.
[42] BULLE E B,KLANDERMAN R B,PENDERGRAST J,et al.The recipe for TACO: A narrative review on the pathophysiology and potential mitigation strategies of transfusion-associated circulatory overload[J]. Blood Rev,2022,52:100891.
[43] WANG M,GOLDGOF G M,PATEL A,et al.Novel computational methods on electronic health record yields new estimates of transfusion-associated circulatory overload in populations enriched with high-risk patients[J]. Transfusion,2023,63(7):1298-1309.
[44] DESAI D S,SHAH K S,SHAH S A.Educational Case: Transfusion reactions: Transfusion associated circulatory overload vs transfusion-related acute lung injury[J]. Acad Pathol,2022,9(1):100022.
[45] ROUBINIAN N H,LOONEY M R,KOR D J,et al.Cytokines and clinical predictors in distinguishing pulmonary transfusion reactions[J]. Transfusion,2015, 55(8):1838-1846.

Expert Consensus on the Clinical Diagnosis and Treatment of Transfusion-associated Circulatory Overload (2026 Edition)

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 7

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	YANG Jianhao, ZHANG Yi, ZHANG Shunwei, LU Yun, QIU Yingjie. Evaluation of Blood Component Sterility Test Results in the Shanghai Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2025, 27(3): 354-359.
[2]	LIANG Chunyan, DUAN Li, LIU Youying, LIU Fangjiu. Risk Factors and Predictive Models of Transfusion-associated Circulatory Overload in Hospitalized Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(6): 771-776.
[3]	LI Huan, XIE Jia, HE Hongwei, et al. Transfusion-related Respiratory Adverse Reactions in Patients with Massive Perioperative Blood Transfusion in Cardiac Surgery：A Retrospective Study [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(3): 358-362.
[4]	YUAN Hai-qing, JING Hong-li, ZHU Li-li, et al. Discussion on the Current Situation of Red Blood Cell Component Blood Inventory Management in 26 Local and Municipal Blood Stations in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2023, 25(2): 204-209.
[5]	YI Xing, YUAN Xiao-hua, BAI Lin, et al. Practical Experience of COVID-19 Convalescent Plasma Collection,Preparation and Distribution by 38 Blood Stations in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(3): 285-290.
[6]	ZHENG Yan-mei, GAO Jian, CHAI Sheng-jiang. Investigation and Analysis of Clinical Blood Work in Xiangyang Area [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(5): 471-473.
[7]	XIANG Ping, GAO Zhi-gang, LIU Jun. Analysis of the Data in Apheresis Platelets Collection in Tianjin District from 2014 to 2016 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2019, 21(1): 27-30.